Русский / English
Enter the query
News
Press Center
phone: +7 495 785 29 07
fax: +7 499 230 32 94
press@interros.ru
Contacts
16.07.2018
The event took place within the framework of the educational project «We and Media». Participants of the round table discussed ways of fighting dangerous infectious diseases and the role of the media in the popularization of the vaccine prophylaxis.
More Topics Petrovax Pharm / vaccine prophylaxis / quadrivalent vaccine
27.11.2017
At the sixth annual Russian Pharma Awards 2017, Polyoxidonium, a Russian combination product that is an immunomodulator, detoxifier, and antioxidant, took the prize for «Product of choice for treating and preventing acute viral respiratory infection in children».
More Topics Petrovax Pharm
10.10.2017
Boehringer Ingelheim has concluded phase one of their localization effort aimed at manufacturing their innovative thrombolytic medicines in Russia: the first batches of Metalyse (tenectaplase) for acute heart attack treatment were produced at NPO Petrovax Pharm facilities.
More Topics Petrovax Pharm
13.01.2017
Researchers compared the 300 most affluent business people and upper-level managers in the largest companies in Russia, both state-owned and private. The ranking was compiled based on the number of mentions in Russia’s main media outlets between January 1 and December 31, 2016; additionally, researchers analyzed print material from 100 leading foreign newspapers and magazines.  Both Forbes and the readers selected Vladimir Potanin as an Entrepreneur with a track record of achievement in large-scale projects that benefit society.
More Topics Charity
23.11.2016
By the end of 2019, the companies intend to complete the transfer of technologies and to launch full-cycle production of innovative thrombolytic medicines at Petrovax Pharm’s production facility in the Moscow Region.
More Topics Petrovax Pharm